Zynerba Pharmaceuticals Ord Shs (ZYNE)

$3.42 0.00 (0.00%)

14:19 EDT ZYNE Stock Quote Delayed 30 Minutes

Volume:

Previous Close $3.42

Market Cap 46.38M

PE Ratio -1.23

EPS -2.79

Volume (Avg. Vol.) 952,877

Day's Range 3.33 - 3.43

52-Week Range 2.55 - 15.30

Dividend & Yield N/A (N/A)

ZYNE Stock Predictions, Articles, and Zynerba Pharmaceuticals Ord Shs News

From InvestorPlace
From the Web

7 Stocks to Buy With 100% Upside Potential

By Maya Sasson, Writer, TipRanks Oct 23, 2019

Investors are looking for the stocks that have the potential to lift their portfolios to new heights. These investments are the stocks with the strongest long-term growth narratives, capable of delivering massive returns.

Zynerba Stock is a Medical Cannabis Investment You Can Feel Good About

By David Moadel, InvestorPlace Contributor Sep 17, 2019

Thinking about investing in medical cannabis? ZYNE stock is a lesser-known gem with transformative potential.

5 Cannabis Stocks Set for Massive Gains

By Harriet Lefton, Writer, TipRanks Aug 26, 2019

We are on the brink of a massive market opportunity. For instance, a new report by Grand View Research reveals that the global legal marijuana market size is expected to reach $66.3 billion by the end of 2025.

3 Marijuana Stocks to Play the Future of Cannabis Medicine

By Aaron Levitt, InvestorPlace Contributor Aug 6, 2019

Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.

Zynerba Stock Soars on Cannabidiol Patent for Autism Spectrum Disorder

By Bret Kenwell, InvestorPlace Contributor Jun 11, 2019

Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.

7 Marijuana Stocks to Play the CBD Trend

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor May 23, 2019

The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.

Compare Brokers

5 Cannabis Stocks Set to Skyrocket — According to Wall Street’s Top Analysts

By Harriet Lefton, Writer, TipRanks Apr 1, 2019

Investors have heard a ton about cannabis stocks and their ridiculous valuations. But Wall Street analysts say these pot stocks still have a lot of upside ahead.